{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Primary lymphoedema",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_bendamustine",
          "name": "Bendamustine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_interferon_alpha",
          "name": "Interferon alpha"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_lymphedema_compression_pump",
          "name": "Lymphedema compression pump"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_pantoprazole",
          "name": "Pantoprazole"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_tamoxifen",
          "name": "Tamoxifen"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_trastuzumab",
          "name": "Trastuzumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_bendamustine",
          "type": "Drug",
          "label": "Bendamustine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexamethasone",
          "type": "Drug",
          "label": "Dexamethasone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_interferon_alpha",
          "type": "Drug",
          "label": "Interferon alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lymphedema_compression_pump",
          "type": "Drug",
          "label": "Lymphedema compression pump",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_pantoprazole",
          "type": "Drug",
          "label": "Pantoprazole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tamoxifen",
          "type": "Drug",
          "label": "Tamoxifen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_trastuzumab",
          "type": "Drug",
          "label": "Trastuzumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_primary_lymphoedema",
          "type": "Disease",
          "label": "Primary lymphoedema",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_immune_response",
          "type": "Target",
          "label": "Immune Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_cell_cycle",
          "type": "Target",
          "label": "Cell Cycle",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_apoptosis",
          "type": "Pathway",
          "label": "Apoptosis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammation",
          "type": "Pathway",
          "label": "Inflammation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_reduction_swelling",
          "type": "Phenotype",
          "label": "Reduction in Swelling",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_immune_modulation",
          "type": "Phenotype",
          "label": "Immune Modulation",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_bendamustine",
          "target": "target_immune_response",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "用于免疫相关疾病的治疗"
        },
        {
          "source": "drug_dexamethasone",
          "target": "target_immune_response",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "广泛用于控制炎症和免疫反应"
        },
        {
          "source": "drug_etoposide",
          "target": "target_cell_cycle",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抑制细胞周期的抗癌药物"
        },
        {
          "source": "drug_interferon_alpha",
          "target": "target_immune_response",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "在多种免疫疾病中的应用"
        },
        {
          "source": "drug_lymphedema_compression_pump",
          "target": "phenotype_reduction_swelling",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "直接针对淋巴水肿的治疗"
        },
        {
          "source": "drug_pantoprazole",
          "target": "pathway_inflammation",
          "relation": "inhibits",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "潜在的抗炎作用"
        },
        {
          "source": "drug_rituximab",
          "target": "target_immune_response",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "用于自身免疫疾病和癌症的治疗"
        },
        {
          "source": "drug_sirolimus",
          "target": "target_immune_response",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "在免疫调节中的应用"
        },
        {
          "source": "drug_tamoxifen",
          "target": "target_cell_cycle",
          "relation": "inhibits",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "抗癌药物，通过影响细胞分裂"
        },
        {
          "source": "drug_thalidomide",
          "target": "pathway_inflammation",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "免疫调节及抗炎特性"
        },
        {
          "source": "drug_trastuzumab",
          "target": "target_immune_response",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "用于HER2阳性癌症的靶向药物"
        },
        {
          "source": "drug_vincristine",
          "target": "target_cell_cycle",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "具有抑制细胞分裂作用的抗癌药物"
        },
        {
          "source": "target_immune_response",
          "target": "phenotype_immune_modulation",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与免疫调节相关表型的联系"
        },
        {
          "source": "target_cell_cycle",
          "target": "phenotype_reduction_swelling",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响细胞分裂的药物与水肿改变间关系"
        },
        {
          "source": "pathway_apoptosis",
          "target": "disease_primary_lymphoedema",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "相关通路在病理表现中的作用"
        },
        {
          "source": "pathway_inflammation",
          "target": "disease_primary_lymphoedema",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "炎症通路与淋巴水肿的关系"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过影响免疫或细胞周期相关靶点对初级淋巴水肿的潜在作用",
        "confidence": "medium"
      },
      {
        "id": "C2",
        "text": "通过靶向通路可能改善初级淋巴水肿的症状",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物在相关组织内的有效浓度满足治疗需求（常识判断）"
    ],
    "uncertainties": [
      "特定药物的安全性与有效性在此适应症中尚未完全验证"
    ],
    "next_focus_for_pi": [
      "是否需要进一步验证靶点的作用机制与安全性？"
    ]
  }
}